Northern Trust
HOWL icon

Northern Trust’s Werewolf Therapeutics HOWL Stock Holding History

Northern Trust’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.3K Hold
86,851
– – ﹤0.01% 4178
2025
Q4 		$55K Buy
86,851
+21,015
+32% +$25.6K ﹤0.01% 4264
2025
Q3 		$130K Hold
65,836
– – ﹤0.01% 4076
2025
Q2 		$71.8K Sell
65,836
-192,622
-75% -$198K ﹤0.01% 4174
2025
Q1 		$251K Buy
258,458
+14,068
+6% +$18.4K ﹤0.01% 3861
2024
Q4 		$362K Buy
244,390
+16,640
+7% +$33.9K ﹤0.01% 3768
2024
Q3 		$483K Buy
227,750
+169,152
+289% +$385K ﹤0.01% 3589
2024
Q2 		$143K Buy
58,598
+10,096
+21% +$48.5K ﹤0.01% 3959
2024
Q1 		$314K Sell
48,502
-1,146
-2% -$6.68K ﹤0.01% 3728
2023
Q4 		$192K Buy
49,648
+23,581
+90% +$60.2K ﹤0.01% 3912
2023
Q3 		$55.8K Hold
26,067
– – ﹤0.01% 4141
2023
Q2 		$79.5K Buy
26,067
+6,161
+31% +$17.3K ﹤0.01% 4098
2023
Q1 		$51.8K Buy
19,906
+1,467
+8% +$4.37K ﹤0.01% 4259
2022
Q4 		$37.8K Sell
18,439
-114
-0.6% -$298 ﹤0.01% 4351
2022
Q3 		$84K Buy
18,553
+4,735
+34% +$25.7K ﹤0.01% 4169
2022
Q2 		$57K Sell
13,818
-181,250
-93% -$827K ﹤0.01% 4371
2022
Q1 		$859K Sell
195,068
-4,997
-2% -$35K ﹤0.01% 3499
2021
Q4 		$2.38M Buy
200,065
+129,661
+184% +$1.96M ﹤0.01% 3141
2021
Q3 		$1.21M Sell
70,404
-5,370
-7% -$91.6K ﹤0.01% 3494
2021
Q2 		$1.32M Buy
+75,774
New +$1.04M ﹤0.01% 3468

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust's HOWL Position: Q1 2026 in Review

Northern Trust held its Werewolf Therapeutics (HOWL) position steady in Q1 2026 at 86,851 shares worth $72.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4178.

Northern Trust first reported a position in HOWL in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.38M in Q4 2021. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Northern Trust held 86,851 shares of Werewolf Therapeutics worth $72.3K as of Q1 2026.
  • Northern Trust left its Werewolf Therapeutics share count unchanged in Q1 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4178 holding.
  • Northern Trust first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Northern Trust's Werewolf Therapeutics position peaked at $2.38M in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.